(OTLK) Outlook Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Outlook Therapeutics | (OTLK) share price targets
Complete technical analysis of Outlook Therapeutics (OTLK) by charts plus indicators, forecast predictions and share price targets for Outlook Therapeutics (OTLK)
Outlook Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-03-17 View latest technical analysis
10 day averaged volume of Outlook Therapeutics is 318895
Date | Daily Closing Price | Open | High | Low | Volume |
17 Mon Mar 2025 | 1.54 | 1.57 | 1.57 | 1.51 | 0.906 times |
14 Fri Mar 2025 | 1.57 | 1.50 | 1.57 | 1.50 | 1.101 times |
13 Thu Mar 2025 | 1.48 | 1.51 | 1.54 | 1.46 | 0.593 times |
12 Wed Mar 2025 | 1.54 | 1.45 | 1.56 | 1.42 | 0.817 times |
11 Tue Mar 2025 | 1.50 | 1.41 | 1.51 | 1.38 | 0.805 times |
10 Mon Mar 2025 | 1.41 | 1.48 | 1.50 | 1.40 | 0.747 times |
07 Fri Mar 2025 | 1.49 | 1.51 | 1.52 | 1.46 | 0.708 times |
06 Thu Mar 2025 | 1.51 | 1.48 | 1.53 | 1.47 | 0.821 times |
05 Wed Mar 2025 | 1.50 | 1.50 | 1.56 | 1.47 | 1.359 times |
04 Tue Mar 2025 | 1.47 | 1.42 | 1.52 | 1.36 | 0.847 times |
My analysis of stock is bullish for shortterm, and stock might move up till 1.6 or till 1.7. Use a stoploss of 1.52 and if this stock hits its stoploss, then it can fall down till 1.44
Share price targets for Outlook Therapeutics (OTLK)
Target Type | Value |
Downside Target | 1.26 |
Downside Target | 1.32 |
Downside Target | 1.36 |
Downside Target | 1.51 |
Upside Target | 1.57 |
Upside Target | 1.80 |
Upside Target | 1.88 |
Upside Target | 1.99 |
Upside Target | 2.18 |
Upside Target | 2.60 |
Upside Target | 4.84 |
Upside Target | 6.98 |
Intraday share price targets for Outlook Therapeutics (OTLK)
Target Type | Value |
Downside Intraday Target | 1.51 |
Downside Intraday Target | 1.48 |
Upside Intraday Target | 1.57 |
Upside Intraday Target | 1.6 |
Downside Intraday Target | 1.54 |
Weekly technical analysis of Outlook Therapeutics (OTLK)
Date | Weekly Closing Price | Open | High | Low | Volume |
17 Mon Mar 2025 | 1.54 | 1.57 | 1.57 | 1.51 | 0.223 times |
14 Fri Mar 2025 | 1.57 | 1.48 | 1.57 | 1.38 | 0.684 times |
07 Fri Mar 2025 | 1.49 | 1.56 | 1.57 | 1.36 | 0.611 times |
28 Fri Feb 2025 | 1.50 | 1.56 | 1.59 | 1.32 | 1.365 times |
21 Fri Feb 2025 | 1.56 | 1.85 | 1.88 | 1.53 | 0.806 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Outlook Therapeutics (OTLK)
Date | Monthly Closing Price | Open | High | Low | Volume |
17 Mon Mar 2025 | 1.54 | 1.56 | 1.57 | 1.36 | 0.288 times |
28 Fri Feb 2025 | 1.50 | 1.97 | 1.99 | 1.32 | 0.565 times |
31 Fri Jan 2025 | 2.06 | 1.90 | 2.60 | 1.80 | 1.161 times |
31 Tue Dec 2024 | 1.89 | 1.53 | 2.18 | 1.26 | 3.293 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Outlook Therapeutics (OTLK)
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Outlook Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Outlook Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Outlook Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Outlook Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Outlook Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.5 and Outlook Therapeutics (OTLK) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Outlook Therapeutics (OTLK) stock. Volume based technical analysis of Outlook Therapeutics (OTLK) stock is negative.
Outlook Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Outlook Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Outlook Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Outlook Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Outlook Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Outlook Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.5 and Outlook Therapeutics (OTLK) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Outlook Therapeutics (OTLK) stock. Volume based technical analysis of Outlook Therapeutics (OTLK) stock is negative.
Outlook Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.